Boehringer Ingelheim

Boehringer Ingelheim is a leading global pharmaceutical company, founded in 1885 and headquartered in Ingelheim am Rhein, Germany. As the largest private pharmaceutical enterprise worldwide, it operates in 76 to 78 countries and employs over 54,000 people. The company reported a revenue of €27.8 billion in 2025. Boehringer Ingelheim focuses on three main business segments: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In Human Pharma, the company addresses unmet medical needs in areas such as respiratory diseases, cardiometabolic disorders, immunology, oncology, and central nervous system disorders. Its notable products include Spiriva, Pradaxa, and Jardiance. In Animal Health, the company provides healthcare solutions for pets and livestock, including vaccines and therapeutics. The company is dedicated to improving health and lives through innovative therapies for both humans and animals.